13 Oct Leede Jones Gable Expands Capital Markets Team
CALGARY, October 13, 2020 – Leede Jones Gable continues to grow its capital markets team, adding strength in healthcare and biotechnology and building on recent additions in sales and trading.
Joining the firm are Michael Lorimer and Doug Loe, who bring more than two decades of senior capital markets experience in healthcare investment banking and research at Canadian investment houses.
Michael Lorimer has raised billions of dollars in growth capital for promising companies and advised on numerous M&A mandates. Doug Loe is one of Canada’s pre-eminent healthcare and biotechnology analysts, recognized by both Starmine and Brendan Wood International.
These new hires follow the recent arrival of Pat McCarthy, Sean Riley, Asha Khosla and Matt Green, who have all joined Leede Jones Gable Capital Markets this year.
“We are thrilled to have Michael and Doug join the firm. We now have the critical mass we need to service our corporate clients. With the new reality of life with Covid-19, we are all more focused on health and wellness,” said Jim Dale, CEO of Leede Jones Gable. “This top-ranked healthcare team is known for finding great investment ideas in healthcare IT, biotechnology, specialty pharma, and med-tech. It is a theme that is very timely and appealing to our retail and institutional clients.”
About Leede Jones Gable
Leede Jones Gable is a mid-size investment firm with offices across Canada and over 150 investment advisors and portfolio managers. We are one of the few full-service dealers not owned by a bank or life insurance company. We are owned by our employees, and that sets the stage for our firm’s ambition and culture. In its 2019 Brokerage Report Card, Investment Executive ranked us the top investment firm in Canada.
FOR MORE INFORMATION CONTACT
Jim Dale, CEO
Leede Jones Gable Inc.